English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Non-specific pulmonary nodules detected in low-dose computed tomography (LDCT) lung cancer screening have been the subject of discussions for years. Lung nodules are detected in 20–50% of high-risk individuals undergoing lung cancer screening and may cause harm for patients due to the need for further CT surveillance or invasive procedures. A high proportion of detected non-specific pulmonary nodules is one of the drawbacks of lung cancer screening programs. Between 2009–2011 in Gdańsk, Poland, we conducted a single-arm observational lung cancer screening program (1) for individuals at high risk of developing lung cancer, aged 50–75, with at least 20 pack-years of smoking history. Among 8,649 people screened, nonspecific pulmonary nodules were found in 54% of participants and non-calcified nodules (NCNs) in 34%. Lung cancer was diagnosed in 1.24% [107] of all participants (1). Subsequently, to evaluate the lung cancer incidence in the study population in the 5 years follow-up we analyzed retrospectively the database of the Polish National Health Fund (pol. Narodowy Fundusz Zdrowia). During the 5 years of follow-up from the end of the screening program, lung cancer was detected in another 382 program participants, so in 4.42% of the whole cohort. The total number of program participants diagnosed with lung cancer was 488 (5.65%) in the period 2009–2016 and the mean annual lung cancer detection rate would have been 0.77% a year if the screening was continued (2). Recently, in Lung Cancer, Pinsky and Gierada published an interesting article entitled “Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans” (3). The authors subjected to a long observation LDCT arm participants of the National Lung Screening Trial (NLST) (4). The risk of lung cancer in trial participants with both a detected lung nodule in the baseline scan and new incidental findings during the followup has been evaluated. Of the 26,309 subjects who underwent low-dose CT, 26.9% [7,090] had a NCN in the baseline examination. The analysis was also carried out from the perspective of specific lung lobes. Among 131,545 lung lobes, nodules were found in 7.2% [9,448] of them. More than 20% of these nodules had a diameter ≥8 mm. The main results were presented in rate-ratios (RRs), which were computed as the ratio of the lung cancer incidence rate in a NCN group divided by the lung incidence rate in a comparison group without NCN. Adjusted RRs for periods 0–4, 4–8 and 8–12 years of followEditorial Commentary

Non-calcified pulmonary nodules detected in low-dose computed tomography lung cancer screening programs can be potential precursors of malignancy